TFM
DNA icon

TFC Financial Management’s Ginkgo Bioworks DNA Stock Holding History

TFC Financial Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.97K Hold
300
– – ﹤0.01% 527
2026
Q1 		$1.84K Hold
300
– – ﹤0.01% 543
2025
Q4 		$2.49K Buy
+300
New +$3.23K ﹤0.01% 514
2022
Q4 		– Sell
-88
Closed -$11K – 541
2022
Q3 		$11K Buy
+88
New +$10.5K ﹤0.01% 306

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

TFC Financial Management's DNA Position: Q2 2026 in Review

TFC Financial Management held its Ginkgo Bioworks (DNA) position steady in Q2 2026 at 300 shares worth $2.97K. The position accounts for ﹤0.01% of the portfolio, ranked #527.

TFC Financial Management first reported a position in DNA in Q3 2022 and has held it in 4 quarters since. The position peaked at $11K in Q3 2022. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • TFC Financial Management held 300 shares of Ginkgo Bioworks worth $2.97K as of Q2 2026.
  • TFC Financial Management left its Ginkgo Bioworks share count unchanged in Q2 2026.
  • Ginkgo Bioworks made up ﹤0.01% of TFC Financial Management's portfolio in Q2 2026, its #527 holding.
  • TFC Financial Management first reported a position in Ginkgo Bioworks in Q3 2022 and has held it in 4 quarters since.
  • TFC Financial Management's Ginkgo Bioworks position peaked at $11K in Q3 2022.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on TFC Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.